Free Trial

Wealth Enhancement Advisory Services LLC Has $1.22 Million Holdings in UiPath Inc. (NYSE:PATH)

UiPath logo with Business Services background

Wealth Enhancement Advisory Services LLC increased its holdings in shares of UiPath Inc. (NYSE:PATH - Free Report) by 164.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 95,469 shares of the healthcare company's stock after buying an additional 59,435 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in UiPath were worth $1,222,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC acquired a new stake in shares of UiPath in the 3rd quarter valued at about $26,000. JTC Employer Solutions Trustee Ltd acquired a new stake in shares of UiPath in the 3rd quarter valued at about $26,000. ORG Partners LLC raised its stake in shares of UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company's stock valued at $27,000 after purchasing an additional 1,112 shares during the period. Hantz Financial Services Inc. acquired a new stake in shares of UiPath in the 2nd quarter valued at about $28,000. Finally, Redwood Wealth Management Group LLC acquired a new stake in shares of UiPath in the 2nd quarter valued at about $43,000. Institutional investors and hedge funds own 62.50% of the company's stock.

Insider Activity

In other news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the sale, the chief financial officer now directly owns 849,917 shares in the company, valued at approximately $10,258,498.19. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 22.37% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

PATH has been the topic of several recent research reports. BMO Capital Markets lifted their price target on UiPath from $14.00 to $15.00 and gave the company a "market perform" rating in a research note on Friday, September 6th. JPMorgan Chase & Co. decreased their price objective on UiPath from $19.00 to $17.00 and set an "overweight" rating for the company in a report on Wednesday, October 23rd. Evercore ISI raised their price objective on UiPath from $13.00 to $16.00 and gave the company an "in-line" rating in a report on Friday, September 6th. Royal Bank of Canada restated a "sector perform" rating and issued a $16.00 price objective on shares of UiPath in a report on Friday, September 6th. Finally, Bank of America raised their price objective on UiPath from $16.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Sixteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $17.47.

View Our Latest Stock Report on PATH

UiPath Trading Up 1.7 %

Shares of NYSE:PATH traded up $0.21 during trading on Tuesday, reaching $12.53. 5,733,144 shares of the stock were exchanged, compared to its average volume of 9,535,059. UiPath Inc. has a 12 month low of $10.37 and a 12 month high of $27.87. The firm has a market cap of $6.89 billion, a PE ratio of -62.70 and a beta of 0.87. The stock has a 50-day moving average price of $12.53 and a 200-day moving average price of $13.73.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The company had revenue of $316.00 million during the quarter, compared to analysts' expectations of $303.69 million. During the same quarter in the previous year, the company posted ($0.09) earnings per share. The business's revenue was up 10.0% on a year-over-year basis. On average, sell-side analysts expect that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

UiPath Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should you invest $1,000 in UiPath right now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines